Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B

NCT00922792 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Haemophilia A
Haemophilia B

Interventions

DRUG: activated recombinant human factor VII, long acting
DRUG: activated recombinant human factor VII, long acting

Sponsor

Novo Nordisk A/S